Dr Catherine Naseriyan

2013

• Mart, R. J. et al. 2013. BH3 helix-derived biophotonic nanoswitches regulate cytochrome c release in permeabilised cells. Molecular BioSystems 9 (11), pp.2597-2603. (10.1039/c3mb70246d)

2010

• Al-Soraj, M. H. et al., 2010. siRNA versus pharmacological inhibition of endocytic pathways for studying cellular uptake of cell penetrating peptides and other drug delivery vectors. Drug Discovery Today 15 (23-24), pp.1103-1103. (10.1016/j.drudis.2010.09.411)
• Fricke, T. et al. 2010. Click chemistry for the generation of cell permeable apoptotic peptides. Drug Discovery Today 15 (23-24), pp.1088-1088. (10.1016/j.drudis.2010.09.375)
• Sweeney, M. et al., 2010. Octaarginine mediated delivery of fluorescent cargo to human smooth muscle cells. Drug Discovery Today 15 (23-24), pp.1085-1085. (10.1016/j.drudis.2010.09.367)
• Watkins, C. L. , Ochonogor, O. and Jones, A. T. 2010. Utilising the fluorescent properties of Laurdan to study plasma membrane fluidity in cells treated with the cell penetrating peptide R8. Drug Discovery Today 15 (23-24), pp.1106-1106.

2009

• Watkins, C. L. et al. 2009. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD. Journal of Controlled Release 140 (3), pp.237-244. (10.1016/j.jconrel.2009.04.028)
• Watkins, C. L. et al. 2009. Low concentration thresholds of plasma membranes for rapid energy-independent translocation of a cell-penetrating peptide. Biochemical Journal 420 (2), pp.179-189. (10.1042/BJ20090042)